191P Evaluating sorafenib as second-line treatment for advanced hepatocellular carcinoma: SORA-2, an European retrospective multicenter study.
Saved in:
| Title: | 191P Evaluating sorafenib as second-line treatment for advanced hepatocellular carcinoma: SORA-2, an European retrospective multicenter study. |
|---|---|
| Authors: | Möhring, C.1 (AUTHOR), Berger, M.2 (AUTHOR), Sadeghlar, F.1 (AUTHOR), Berres, M-L.3 (AUTHOR), Radu, I-P.4 (AUTHOR), Roderburg, C.5 (AUTHOR), Vogel, A.6 (AUTHOR), Sinner, F.7 (AUTHOR), Pirozzi, A.8 (AUTHOR), Weinmann, A.9 (AUTHOR), Ehmer, U.10 (AUTHOR), Ben Khaled, N.11 (AUTHOR), Ettrich, T.J.12 (AUTHOR), Pinter, M.13 (AUTHOR), Schmidt-Wolf, I.14 (AUTHOR), Schmid, M.2 (AUTHOR), Strassburg, C.P.1 (AUTHOR), Gonzalez Carmona, M.A.1 (AUTHOR) |
| Source: | Annals of Oncology. 2024 Supplement 1, Vol. 35, pS86-S86. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2024.05.200 |
